Table 2.
Case 1 | Case 2 | Case 3 | Case 4 | |
---|---|---|---|---|
Age (decade of life) | 9th | 6th | 6th | 3rd |
Sex | male | male | male | male |
Co-morbidity | DM | DM, COPD | HTN, COPD | Nil |
Anti-TB regimen before ABE | HREZ | HREZ | HREZ | HRE |
Presenting symptoms | Fever/Chills | Nausea/Vomiting | Fever | Abdominal pain |
Peak ALT level (U/L)a | 375 | 303 | 16 | 499 |
Peak AST level (U/L)b | 212 | 223 | 98 | 303 |
Peak total bilirubin level (mg/dL)c | 2.81 | 1.53 | 1.69 | 0.57 |
Diagnosis of ABE | Cholecystitis | Cholecystitis | Cholelithiasis with biliary obstruction | Cholelithiasis with biliary obstruction |
Onset of ABE | 1 week later | 4 weeks later | 2 weeks later | 18 weeks later |
Treatment of ABE | LC | Antibiotics | Antibiotics | Antibiotics |
ABE Acute biliary event, ALT Alanine aminotransferase, AST Aspartate aminotransferase, COPD Chronic obstructive pulmonary disease, DM Diabetes mellitus, E Ethambutol, H Isoniazid, HTN Hypertension, LC laparoscopic cholecystectomy, R Rifampin, TB Tuberculosis, Z Pyrazinamide
anormal range of ALT: 2–32 U/L
bnormal range of AST: 10–30 U/L
cnormal range of total bilirubin: 0.2–1.2 mg/dL